apollo
0
Prescription drug
 Trailing icon
Consult Doctor

Composition

MEGESTROL-40MG

Manufacturer/Marketer

Getwell Oncology Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-25

for this medicine

About Megetra 40 Tablet

Megetra 40 Tablet is used as a symptomatic treatment in patients with breast cancer and endometrial cancer. Breast cancer develops in cells of the breast cells and is characterized by a lump in the breast, a change in the shape of the nipple or breast, and bloody discharge from the nipples. Endometrial cancer is the cancer of the womb's lining (uterus), characterized by pelvic pain, bleeding between periods, and pain during sex.

Megetra 40 Tablet contains ‘Megestrol’, which belongs to the class of ‘Progestogens’. It works similarly to the female hormone ‘progesterone’. It interferes with the production or action of hormones involved in cancer growth. This effect helps to slow down the progression of cancer and reduce the symptoms associated with cancer.

You should take this medicine exactly as your doctor prescribed. The common side-effects of Megetra 40 Tablet are an increase in appetite, weight gain, shortness of breath, hot flushes (reddening of the face and neck), high blood pressure, increased blood sugar levels, rounded face, constipation, and swelling of a vein due to a blood clot. If any of these side effects persist or get worse, inform your doctor immediately.

Do not take Megetra 40 Tablet if allergic to Megestrol or any contents. Before taking Megetra 40 Tablet , inform your doctor if you have severe liver problems, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorder, and diabetes. Megetra 40 Tablet should be used with caution in elderly patients. Megetra 40 Tablet is not recommended for children, pregnant women, and breastfeeding mothers. Do not consume alcohol, as it may increase the risk of side effects. Megetra 40 Tablet may not affect your ability to drive.

Uses of Megetra 40 Tablet

Megetra 40 Tablet is used in the treatment of Breast cancer and endometrial cancer.

Medicinal Benefits

Megetra 40 Tablet contains Megestrol, which is used to treat breast and endometrial cancer. It acts by interfering with the production of hormones that cause cancer's development. It helps to reduce cancer symptoms effectively. It can also be used to treat loss of appetite in patients with HIV/AIDS.

Side Effects of Megetra 40 Tablet

  • Increase in appetite
  • Weight gain
  • Shortness of breath
  • Hot flushes (reddening of the face and neck)
  • High blood pressure
  • Increased blood sugar levels
  • Rounded face
  • Constipation
  • Swelling of a vein due to a blood clot

Directions for Use

Tablets: Swallow the tablet as a whole with a glass of water. Do not crush, chew, or break it. It can be taken with or without food.Oral suspension: Shake the bottle well before each use. Take the prescribed dose of liquid medicine with a marked measuring spoon, oral syringe, or medicine cup, followed by water. Do not use a household spoon to measure the medicine.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Megetra 40 Tablet increases the risk of blood clots, so it should be used cautiously in patients with a history of thrombophlebitis. Also, if you notice impaired coordination, difficulty speaking, pain in the groin, pain in the arm or leg (especially in the calf of the leg), shortness of breath, general weakness, headache, and dizziness, inform your doctor immediately as it may be a sign of blood clot. Megetra 40 Tablet is not recommended for use in pregnancy. Use a reliable contraceptive method to prevent pregnancy while using this medicine. You may also need to take a pregnancy test before using this medicine. Megetra 40 Tablet contains lactose, so inform your doctor if you have an intolerance to any sugars.

Therapeutic Class

PROGESTINS

Drug Interactions

Drug-Drug Interactions: Megetra 40 Tablet may interact with a medicine used to treat heart rhythm disorders (dofetilide) and an anticoagulant (warfarin).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Megetra 40 Tablet should be used with caution in patients with severe liver problems, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorder, and diabetes.

Drug-Drug Interactions Checker List

  • DOFETILIDE
  • WARFARIN

Diet & Lifestyle Advise

  • Eat a healthy diet. Avoid fast food, fried food, processed meats, refined carbs, and added sugar.
  • Drink plenty of fluids and eat fibre-rich food to prevent constipation.
  • Manage your weight. Shed excess weight by exercising regularly if you are obese or overweight.
  • Wear loose, layered clothing during the nighttime, especially in warm weather. This prevents hot flushes.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, herbs, and spices.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.

Habit Forming

No

What if I have taken an overdose of Megetra 40 Tablet

Do not take more than the prescribed dose of Megetra 40 Tablet as it may cause overdose. If you suspect you have taken overdose, please consult a doctor immediately.

Special Advise

  • If you are undergoing surgery, inform your doctor that you are taking Megetra 40 Tablet as it may interfere with healing.
  • Please do not stop taking Megetra 40 Tablet without discussing it with your doctor.
  • Your doctor may advise you to monitor blood pressure regularly and take blood tests to evaluate liver and kidney function while using Megetra 40 Tablet .

Disease/Condition Glossary

Breast cancer: It is a type of cancer that develops in breast cells. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), fatty tissue, or the fibrous connective tissue within the breast. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.  The risk factors of breast cancer are increasing age, family history of breast cancer, and obesity.

Endometrial cancer: It is a type of cancer in which the endometrium (lining of the womb or uterus) is affected. It is usually seen in women above the age of 55 years. Symptoms include bleeding between periods, pelvic pain, and pain during sexual intercourse. Endometrial cancer risk factors are increasing age, obesity, never been pregnant, family history of cancer, and diabetes. This condition is not life-threatening when it is diagnosed and treated in the early stages.

bannner image

Alcohol

Caution

Alcohol consumption may increase the risk of side effects and worsen the disease. So, avoid alcohol consumption while using this medicine.

bannner image

Pregnancy

Unsafe

Megetra 40 Tablet should not be used in pregnant women as it may cause birth defects in the unborn baby. Women who are of childbearing potential should obtain a negative pregnancy test before using this medicine.

bannner image

Breast Feeding

Unsafe

Megetra 40 Tablet is not recommended for use in breastfeeding as it may pass into breastmilk and harm your infant.

bannner image

Driving

Safe if prescribed

Megetra 40 Tablet may not affect your ability to drive.

bannner image

Liver

Caution

Megetra 40 Tablet should be used with caution if you have liver disease. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Caution

Megetra 40 Tablet should be used with caution if you have kidney disease. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Megetra 40 Tablet is not recommended for use in children below 12 years of age.

Country of origin

INDIA

Manufacturer/Marketer address

464, Udyog Vihar, Phase-V Sector 19, Gurugram Haryana 122016
Other Info - MEG0455

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Megetra 40 Tablet is used for the treatment of Breast cancer and Endometrial cancer.
Megetra 40 Tablet contains Megestrol, which works similarly to the female hormone progesterone. It interferes with the production or action of hormones involved in cancer growth. This effect helps to slow down the progression of cancer and reduce the symptoms associated with cancer.
Megetra 40 Tablet may increase appetite and cause weight gain. You may gain weight, especially in the waist and the upper back. This effect usually decreases after discontinuing the treatment. However, opt for a healthy diet, exercise regularly, and maintain a normal weight while using this medicine.
Megetra 40 Tablet may not affect fertility but may disrupt the menstrual cycle (periods). Though this medicine affects periods, you should take reliable contraceptive measures while using Megetra 40 Tablet to prevent pregnancy as it may cause harmful effects to the unborn baby.
Megetra 40 Tablet may increase blood glucose levels, so inform your doctor that you have diabetes before taking this medicine. If prescribed, you should monitor blood glucose levels regularly during the treatment.
Megetra 40 Tablet is not a contraceptive and doesn't help to prevent pregnancy. It would be best to discuss the possible benefits and risks associated with this medicine with your doctor before using it.
It is recommended that you complete the course of Megetra 40 Tablet even if you feel better. To treat your condition effectively, continue taking Megetra 40 Tablet for as long as your doctor has prescribed it.
If you miss the dose of Megetra 40 Tablet , take it as soon as you remember. If it is almost time for the next dose, skip the forgotten dose and go back to your regular schedule. Do not take double the dose to compensate for the forgotten dose.
Take Megetra 40 Tablet at around the same time(s) every day. Follow the directions on your prescription label or as directed by the physician.
Megetra 40 Tablet may disrupt the menstrual cycle (periods). If you experience any discomfort please consult the doctor for appropriate treatment plan.
Megetra 40 Tablet is a hormonal therapy drug used to treat breast and womb cancer.
No, it is recommended not to be used while pregnant. Tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking megestrol, call your doctor immediately. Megestrol may harm the foetus.
Megetra 40 Tablet may interfere with women's normal menstrual cycle (period). However, it would be best not to assume you cannot become pregnant. Seek medical advice from your healthcare personnel if you are pregnant and plan to become pregnant.
No, do not refrigerate. It should be stored in a cool and dry place away from sunlight.
No, there is no clinically proven indication to treat hot flushes with Megetra 40 Tablet .
The common side-effects of Megetra 40 Tablet are an increase in appetite, weight gain, shortness of breath, hot flushes (reddening of the face and neck), high blood pressure, increased blood sugar levels, rounded face, constipation, and swelling of a vein due to a blood clot. If any of these side effects persist or get worse, inform your doctor immediately.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.